EDGAR Filing Documents for 0001564590-16-017301

Form 8-K - Current report:

SEC Accession No. 0001564590-16-017301

Filing Date

2016-05-02

Accepted

2016-05-02 16:12:51

Documents

Period of Report

2016-05-02

Items

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	ceru-8k_20160502.htm	8-K	34210
2	EX-99.1	ceru-ex991_15.htm	EX-99.1	45818
3	GRAPHIC	gp1m11szlnzz000001.jpg	GRAPHIC	42424
	Complete submission text file	0001564590-16-017301.txt		139679

Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451

Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 781-996-4300

Cerulean Pharma Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36395 | Film No.: 161611783
SIC: 2834 Pharmaceutical Preparations